Chengzi I Kaku

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 12

Top Topics

Genetic Diversity

Respiratory Syndrome Coronavirus

Saccharomyces Cerevisiae

Advanced Non Small Cell Lung Cancer

Top Venues

Nature communications

Science (New York, N.Y.)

Science translational medicine

bioRxiv : the preprint server for biology

This page only lists publications with an associated author ORCID identifier.

Publications

Chengzi I Kaku, Tyler N Starr, Panpan Zhou, Haley L Dugan, Paul Khalifé, Sophie Ge Song, Elizabeth R Champney, Daniel W Mielcarz, James C Geoghegan, Dennis R Burton, Raiees Andrabi, Jesse D Bloom, Laura M Walker
Evolution of antibody immunity following Omicron BA.1 breakthrough infection. Nature communications 14 (1) (2023)
Ruth I Connor, Mrunal Sakharkar, C Garrett Rappazzo, Chengzi I Kaku, Nicholas C Curtis, Seungmin Shin, Wendy F Wieland-Alter, Joshua A Weiner, Margaret E Ackerman, Laura M Walker, Jiwon Lee, Peter F Wright
Characteristics and functions of infection-enhancing antibodies to the N-terminal domain of SARS-CoV-2. bioRxiv : the preprint server for biology (2023)
Pete Schmidt, Kristin Narayan, Yong Li, Chengzi I Kaku, Michael E Brown, Elizabeth Champney, James C Geoghegan, Maximiliano Vásquez, Eric M Krauland, Thomas J Yockachonis, Shuangyi Bai, Bronwyn M Gunn, Anthony Cammarata, Christopher M Rubino, Paul Ambrose, Laura M Walker
Antibody-mediated protection against symptomatic COVID-19 can be achieved at low serum neutralizing titers. Science translational medicine 15 (688) (2023)
Pete Schmidt, Kristin Narayan, Yong Li, Chengzi I Kaku, Michael E Brown, Elizabeth Champney, James C Geoghegan, Maximiliano Vásquez, Eric M Krauland, Thomas J Yockachonis, Shuangyi Bai, Bronwyn M Gunn, Anthony Cammarata, Christopher M Rubino, Paul Ambrose, Laura M Walker
Antibody-mediated protection against symptomatic COVID-19 can be achieved at low serum neutralizing titers. Science translational medicine 15 (688) (2023)
Chengzi I Kaku, Tyler N Starr, Panpan Zhou, Haley L Dugan, Paul Khalifé, Sophie Ge Song, Elizabeth R Champney, Daniel W Mielcarz, James C Geoghegan, Dennis R Burton, Raiees Andrabi, Jesse D Bloom, Laura M Walker
Evolution of antibody immunity following Omicron BA.1 breakthrough infection. Nature communications 14 (1) (2023)
Chengzi I Kaku, Tyler N Starr, Panpan Zhou, Haley L Dugan, Paul Khalifé, Sophie Ge Song, Elizabeth R Champney, Daniel W Mielcarz, James C Geoghegan, Dennis R Burton, Raiees Andrabi, Jesse D Bloom, Laura M Walker
Evolution of antibody immunity following Omicron BA.1 breakthrough infection. Nature communications 14 (1) (2023)
Chengzi I Kaku, Elizabeth R Champney, Johan Normark, Marina García, Carl E Johnson, Clas Ahlm, Wanda Christ, Mrunal Sakharkar, Margaret E Ackerman, Jonas Klingström, Mattias N E Forsell, Laura M Walker
Broad anti-SARS-CoV-2 antibody immunity induced by heterologous ChAdOx1/mRNA-1273 vaccination. Science (New York, N.Y.) 375 (6584) (2022)
Hejun Liu, Chengzi I Kaku, Ge Song, Meng Yuan, Raiees Andrabi, Dennis R Burton, Laura M Walker, Ian A Wilson
Human antibodies to SARS-CoV-2 with a recurring YYDRxG motif retain binding and neutralization to variants of concern including Omicron. Communications biology 5 (1) (2022)
Chengzi I Kaku, Tyler N Starr, Panpan Zhou, Haley L Dugan, Paul Khalifé, Sophie Ge Song, Elizabeth R Champney, Daniel W Mielcarz, James C Geoghegan, Dennis R Burton, Raiees Andrabi, Jesse D Bloom, Laura M Walker
Evolution of antibody immunity following Omicron BA.1 breakthrough infection. bioRxiv : the preprint server for biology (2022)
Chengzi I Kaku, Alan J Bergeron, Clas Ahlm, Johan Normark, Mrunal Sakharkar, Mattias N E Forsell, Laura M Walker
Recall of preexisting cross-reactive B cell memory after Omicron BA.1 breakthrough infection. Science immunology 7 (73) (2022)
Mrunal Sakharkar, C Garrett Rappazzo, Wendy F Wieland-Alter, Ching-Lin Hsieh, Daniel Wrapp, Emma S Esterman, Chengzi I Kaku, Anna Z Wec, James C Geoghegan, Jason S Mclellan, Ruth I Connor, Peter F Wright, Laura M Walker
Prolonged evolution of the human B cell response to SARS-CoV-2 infection. Science immunology 6 (56) (2021)
C Garrett Rappazzo, Longping V Tse, Chengzi I Kaku, Daniel Wrapp, Mrunal Sakharkar, Deli Huang, Laura M Deveau, Thomas J Yockachonis, Andrew S Herbert, Michael B Battles, Cecilia M O'Brien, Michael E Brown, James C Geoghegan, Jonathan Belk, Linghang Peng, Linlin Yang, Yixuan J Hou, Trevor D Scobey, Dennis R Burton, David Nemazee, John M Dye, James E Voss, Bronwyn M Gunn, Jason S Mclellan, Ralph S Baric, Lisa E Gralinski, Laura M Walker
Broad and potent activity against SARS-like viruses by an engineered human monoclonal antibody. Science (New York, N.Y.) 371 (6531) (2021)